Literature DB >> 8283973

Myocardial expression of atrial natriuretic factor gene in early stages of hamster cardiomyopathy.

P Di Nardo1, M Minieri, A Carbone, N Maggiano, R Micheletti, G Peruzzi, G Tallarida.   

Abstract

Ventricular cardiomyocytes represent the most important source of atrial natriuretic factor (ANF) in pathological conditions such as congestive heart failure (CHF). It has been suggested that in cardiomyopathic Syrian hamster ventricles the ANF gene can be reactivated during the hypertrophic stage occurring before heart failure. The present study was undertaken to investigate ANF gene expression during early stages of myocardial damage and its distribution throughout atrial and ventricular myocardium in UM-X7.1 cardiomyopathic Syrian hamsters (CMPH) before hypertrophy and cardiac failure occur. Atria, right and left ventricles, and interventricular septum of hearts of 20-23 days old (young) and 90-95 days old (adult) CMPH were studied. The absence of hypertrophy and cardiac failure was preliminarly ascertained by microscopic and hemodynamic evaluation. ANF-mRNA as well as tissue and plasma immunoreactive ANF were assayed. Moreover, ANF secretion pattern was evaluated by immunocytochemical techniques. Young and adult CMPH hearts were in the necrotic stage of myocardial disease, as demonstrated by histopathological evaluation and by decreased wet weights (mg/g body weight) of different heart regions. Hemodynamic assessment showed no significant changes of left ventricular end-diastolic pressure (LVEDP) and a decrease of the left ventricular peak systolic pressure (LVSP) and +dP/dt. Plasma immunoreactive ANF (IR-ANF) levels were higher in young (3-fold) and adult (6-fold) CMPH than in age-matched normal hamsters. A reduced IR-ANF concentration (per milligram protein) was observed in both young and adult cardiomyopathic atria in respect to healthy controls, whereas a higher IR-ANF concentration was present in ventricles. A 3-fold, 6-fold and 20-fold increase of IR-ANF concentration was found in right ventricular free-wall (RV), left ventricular free-wall (LV) and interventricular septum (IVS), respectively. Northern-blot analysis confirmed that IVS was the major site of ventricular ANF-mRNA transcription in both young and adult CMPH. ANF-mRNA was increased also in atria where a faster peptide secretion can be hypothesized to lower tissue IR-ANF concentration. ANF secretion in ventricular myocardium was achieved via constitutive pathway as demonstrated by immunocytochemistry. Different patterns of ANF gene reactivation occur in CMPH myocardium before intraventricular pressure increases and structural hypertrophic modifications are detectable. The extent of ANF gene reactivation in CMPH ventricles parallels the severity of necrotic damage. Moreover, ANF gene expression is heterogeneously distributed throughout the myocardium, suggesting that interventricular septum, the ontogenically youngest heart region, might preserve foetal characters which can be rapidly reactivated in pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8283973     DOI: 10.1007/BF00936447

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  40 in total

1.  Ventricular expression of atrial natriuretic peptide.

Authors:  H Tsuchimochi; Y Yazaki; H Ohno; R Takanashi; F Takaku
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

2.  Molecular cloning and characterization of DNA sequences encoding rat and human atrial natriuretic factors.

Authors:  R A Zivin; J H Condra; R A Dixon; N G Seidah; M Chrétien; M Nemer; M Chamberland; J Drouin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

3.  Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. I. Progression of heart and skeletal muscle lesions in the UM-X7.1 line.

Authors:  G Jasmin; L Proschek
Journal:  Muscle Nerve       Date:  1982-01       Impact factor: 3.217

4.  Identification of a biologically active circulating form of rat atrial natriuretic factor.

Authors:  G Thibault; C Lazure; E L Schiffrin; J Gutkowska; L Chartier; R Garcia; N G Seidah; M Chrétien; J Genest; M Cantin
Journal:  Biochem Biophys Res Commun       Date:  1985-08-15       Impact factor: 3.575

5.  Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptide.

Authors:  D Schwartz; D M Geller; P T Manning; N R Siegel; K F Fok; C E Smith; P Needleman
Journal:  Science       Date:  1985-07-26       Impact factor: 47.728

6.  mRNA sequence for human cardiodilatin-atrial natriuretic factor precursor and regulation of precursor mRNA in rat atria.

Authors:  K Nakayama; H Ohkubo; T Hirose; S Inayama; S Nakanishi
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

7.  Atrial natriuretic factor: a hormone produced by the heart.

Authors:  A J de Bold
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

8.  ANF in experimental congestive heart failure.

Authors:  M Cantin; G Thibault; J F Ding; J Gutkowska; R Garcia; G Jasmin; P Hamet; J Genest
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

9.  Ventricles as a major site of atrial natriuretic factor synthesis and release in cardiomyopathic hamsters with heart failure.

Authors:  G Thibault; M Nemer; J Drouin; J P Lavigne; J Ding; C Charbonneau; R Garcia; J Genest; G Jasmin; M Sole
Journal:  Circ Res       Date:  1989-07       Impact factor: 17.367

10.  Atrial natriuretic peptide distribution in fetal and failed adult human hearts.

Authors:  H Tsuchimochi; F Kurimoto; K Ieki; H Koyama; F Takaku; M Kawana; S Kimata; Y Yazaki
Journal:  Circulation       Date:  1988-10       Impact factor: 29.690

View more
  4 in total

1.  Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds.

Authors:  Milica Radisic; Hyoungshin Park; Helen Shing; Thomas Consi; Frederick J Schoen; Robert Langer; Lisa E Freed; Gordana Vunjak-Novakovic
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-16       Impact factor: 11.205

2.  Cardiac chamber-specific alterations of ANP and BNP expression with advancing age and with systemic hypertension.

Authors:  V Raizada; K Thakore; W Luo; P G McGuire
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

3.  Biomimetic approach to cardiac tissue engineering.

Authors:  M Radisic; H Park; S Gerecht; C Cannizzaro; R Langer; G Vunjak-Novakovic
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

4.  Atrophic cardiomyocyte signaling in hypertensive heart disease.

Authors:  German Kamalov; Wenyuan Zhao; Tieqiang Zhao; Yao Sun; Robert A Ahokas; Tony N Marion; Fahed Al Darazi; Ivan C Gerling; Syamal K Bhattacharya; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2013-12       Impact factor: 3.105

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.